Larry Ellison Cancels 10b5-1 Plan to Sell Up to 50M Oracle Shares
ORCL sits 27% above its 52-week low of $114.5 on elevated volume (2.5× avg).
Summary
Oracle announced that Larry Ellison has cancelled his 10b5-1 plan to sell up to 50 million shares, with no shares sold under the plan. He has no other plans to sell Oracle stock.
Key Events · Ownership and Investor Activity · ORCL
-
Ellison Cancels 10b5-1 Sale Plan
Larry Ellison, Executive Chair and CTO, cancelled his 10b5-1 plan to sell Oracle stock on September 12, 2026. No shares were sold under the plan prior to termination.
-
Up to 50M Share Overhang Removed
The 10-Q filed September 11, 2026 disclosed Ellison had adopted a plan to sell up to 50 million shares. At the current price of $145.35, that represented a potential distribution of roughly $7.3 billion.
-
No Other Sale Plans
Ellison stated he has no other plans to sell any of his Oracle stock, removing near-term insider selling pressure.
-
Context: $20B ATM Just Completed
Oracle fully utilized its $20 billion ATM program in Q1 FY2027 (141 million shares for $19.9 billion). The cancellation of Ellison's sale plan removes an additional source of supply.
Analysis · ORCL · Technology
Ellison's cancellation removes a significant overhang on Oracle's stock. The 10-Q filed three days ago disclosed he had adopted a plan to sell up to 50 million shares — a potential multi-billion-dollar distribution at current prices. That plan is now terminated with zero shares sold, and Ellison states he has no other plans to sell. For a company that just completed a $20 billion ATM offering and is funding a massive AI capex cycle, removing insider selling pressure is a meaningful positive for the stock.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 29.3% of the 1516 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ORCL was trading at $145.35 on NYSE in the Technology sector, with a market capitalization of approximately $432.9B. The 52-week trading range was $114.50 to $331.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.